Additionally, recent evidence suggests that hydrogen sulfide (H2S) donors may exert protective effects by inhibiting PAD4, Cit-H3, and MPO expression, and by suppressing NF-κB and HMGB1 signaling pathways in TNBS-induced colitis models [289]. Here, HMGB1 is linked to colitis.